Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)
- Status
- COMPLETED
- Phase
- PHASE3
Postoperative New-onset Atrial Fibrillation in Cardiac Surgery: DECS-PNAF Project
- Status
- COMPLETED
- Phase
- PHASE4
Dexamethasone Efficacy in HELLP I Syndrome
- Status
- UNKNOWN
- Phase
- PHASE3
VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)
- Status
- UNKNOWN
- Phase
- PHASE3
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Neural and Pharmacological Correlates of Intrusions in Patients With Posttraumatic Stress Disorder
- Status
- COMPLETED
- Phase
- NA
Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis
- Status
- COMPLETED
- Phase
- PHASE2
Aplidin - Dexamethasone in Relapsed/Refractory Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Dexamethasone for Prevent Vomiting in Leukemic Children Who Receive Intrathecal Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE4
Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects
- Status
- COMPLETED
- Phase
- PHASE3
Extinction of Fear Memories With Glucocorticoids in Veterans With PTSD
- Status
- COMPLETED
- Phase
- NA
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
The Efficacy of Topical Minocycline in Managing Symptomatic Oral Lichen Planus
- Status
- UNKNOWN
- Phase
- PHASE3
Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3